☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Specialty
Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B
February 10, 2021
Boston Scientific to Divest BTG's Specialty Pharma Business for ~$800M
December 2, 2020
Innovate Merging with RDD Pharma to Form New Gastroenterology Company Focusing on Specialty Rare and Orphan Diseases
October 8, 2019
Load more...
Back to Home